Loading...
ROCO
4160
Market cap31mUSD
Jul 09, Last price  
41.65TWD
1D
-1.30%
1Q
-8.46%
Jan 2017
60.87%
IPO
3.25%
Name

Genetics Generation Advancement Corp

Chart & Performance

D1W1MN
ROCO:4160 chart
P/E
47.07
P/S
1.67
EPS
0.88
Div Yield, %
4.44%
Shrs. gr., 5y
1.09%
Rev. gr., 5y
6.36%
Revenues
603m
-8.88%
429,384,000443,130,000519,511,000547,809,000592,500,000661,855,000603,113,000
Net income
21m
-60.77%
18,304,000-15,705,0007,839,00025,731,00028,565,00054,698,00021,456,000
CFO
-18m
L
026,692,0007,324,00051,808,00066,857,00081,616,000-18,332,000
Dividend
Oct 03, 20251.84733 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Genetics Generation Advancement Corp. (GGAC), headquartered in Taipei, Taiwan, specializes in providing advanced genetic testing and bioinformatics solutions. The company serves a diverse global clientele across Taiwan, Asia, Europe, and the Americas. GGAC offers a comprehensive array of genetic screenings tailored for various life stages and health needs. These include pre-conception, prenatal, and newborn testing, in addition to adult health management, cancer predisposition, and pharmacogenetic analyses. The company also collaborates with and provides services to institutional partners. Beyond its core genetic services, Genetics Generation Advancement Corp. extends its expertise to encompass life sciences, materials science, sophisticated laboratory informatics, enterprise quality management systems (EQMS), Manufacturing Execution Systems (MES), and efficient electronic data delivery solutions. Originally founded in 2008 as Genesis Genetics Asia Corp., the company officially rebranded and adopted its current name, Genetics Generation Advancement Corp., in February 2016.
IPO date
Jul 15, 2011
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT